1.98
price down icon5.71%   -0.12
after-market After Hours: 2.04 0.06 +3.03%
loading
Tenaya Therapeutics Inc stock is traded at $1.98, with a volume of 8.11M. It is down -5.71% in the last 24 hours and up +65.00% over the past month. Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$2.10
Open:
$2.17
24h Volume:
8.11M
Relative Volume:
2.26
Market Cap:
$322.69M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-1.50
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
+15.12%
1M Performance:
+65.00%
6M Performance:
+301.70%
1Y Performance:
+11.86%
1-Day Range:
Value
$1.93
$2.20
1-Week Range:
Value
$1.68
$2.35
52-Week Range:
Value
$0.36
$4.01

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Name
Name
Tenaya Therapeutics Inc
Name
Phone
415-865-2066
Name
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Name
Employee
97
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
TNYA's Discussions on Twitter

Compare TNYA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TNYA
Tenaya Therapeutics Inc
1.98 342.25M 0 -111.13M -91.53M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-10-24 Initiated William Blair Outperform
Nov-30-23 Initiated Leerink Partners Outperform
Jun-15-22 Initiated H.C. Wainwright Buy

Tenaya Therapeutics Inc Stock (TNYA) Latest News

pulisher
11:32 AM

Momentum divergence signals in Tenaya Therapeutics Inc. chartJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - newser.com

11:32 AM
pulisher
10:28 AM

Intraday pattern recognizer results for Tenaya Therapeutics Inc.Trade Risk Report & AI Enhanced Trade Execution Alerts - newser.com

10:28 AM
pulisher
10:13 AM

What Fibonacci levels say about Tenaya Therapeutics Inc. reboundJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com

10:13 AM
pulisher
09:10 AM

Should you wait for a breakout in Tenaya Therapeutics Inc.July 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com

09:10 AM
pulisher
08:24 AM

Statistical indicators supporting Tenaya Therapeutics Inc.’s strengthJuly 2025 Sector Moves & Safe Entry Point Alerts - newser.com

08:24 AM
pulisher
Oct 11, 2025

What analysts say about Tenaya Therapeutics Inc stockEarnings Call Summaries & Affordable Growth Trading - earlytimes.in

Oct 11, 2025
pulisher
Oct 10, 2025

Tenaya Therapeutics (TNYA): Evaluating Valuation After Investor Buzz on MyPEAK-1 and RIDGE-1 Clinical Updates - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Real time scanner hits for Tenaya Therapeutics Inc. explainedEarnings Trend Report & Verified Entry Point Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Tenaya Therapeutics Stock (TNYA) Opinions on CEO Conference Appearances - Quiver Quantitative

Oct 10, 2025
pulisher
Oct 10, 2025

When Will Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Become Profitable? - 富途牛牛

Oct 10, 2025
pulisher
Oct 10, 2025

What to expect from Tenaya Therapeutics Inc. in the next 30 daysPortfolio Return Report & Low Volatility Stock Suggestions - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why Tenaya Therapeutics Inc. stock appeals to analystsDay Trade & AI Powered Market Trend Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Tenaya Therapeutics (NASDAQ:TNYA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference - The Manila Times

Oct 09, 2025
pulisher
Oct 09, 2025

Fireside chat Oct 14: Tenaya Therapeutics CEO Faraz Ali at H.C. Wainwright; 1x1 meetings Oct 15, replay 30 days - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Can Tenaya Therapeutics’ Leadership Messaging Shape Long-Term Perceptions and Value Creation for TNYA? - Yahoo Finance

Oct 09, 2025
pulisher
Oct 06, 2025

Using RSI to spot recovery in Tenaya Therapeutics Inc.Earnings Beat & Accurate Technical Buy Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is now a turning point for Tenaya Therapeutics Inc.July 2025 Update & Trade Opportunity Analysis - newser.com

Oct 06, 2025
pulisher
Oct 03, 2025

Does Tenaya Therapeutics Inc. fit your quant trading model2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What recovery options are there for Tenaya Therapeutics Inc.Trade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Tenaya Therapeutics CEO Faraz Ali to Speak at Upcoming Investor and Industry Conferences in October 2025 - Quiver Quantitative

Oct 02, 2025
pulisher
Oct 02, 2025

Tenaya Therapeutics to Participate in Upcoming October Investor Conferences - The Manila Times

Oct 02, 2025
pulisher
Oct 02, 2025

Oct 6 & Oct 21: Tenaya Therapeutics CEO Faraz Ali to Present at Investor Conferences — Webcast Archived 30 Days - Stock Titan

Oct 02, 2025
pulisher
Sep 29, 2025

Will Strategic Partnerships Propel SP Refractories Limited Higher in YEARExit Strategy Tips & Maximize Returns With Insights - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

How to manage a losing position in Tenaya Therapeutics Inc.Market Trend Report & Weekly Stock Breakout Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What sentiment indicators say about Tenaya Therapeutics Inc. stockEarnings Overview Summary & Step-by-Step Swing Trade Plans - newser.com

Sep 29, 2025
pulisher
Sep 23, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Is Tenaya Therapeutics Inc. trending in predictive chart modelsPortfolio Growth Summary & Consistent Return Investment Signals - newser.com

Sep 23, 2025

Tenaya Therapeutics Inc Stock (TNYA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Tenaya Therapeutics Inc Stock (TNYA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Tingley Whittemore
Chief Medical Officer
Aug 18 '25
Sale
1.25
5,053
6,331
172,803
Ali Faraz
Chief Executive Officer
Aug 18 '25
Sale
1.25
14,533
18,210
302,792
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):